\BOOKMARK [0][-]{chapter*.6}{Preamble\040about\040Interdisciplinary\040Research}{}% 1
\BOOKMARK [1][-]{section*.7}{What\040does\040interdisciplinarity\040in\040science\040mean\040in\040XXI\040century?}{chapter*.6}% 2
\BOOKMARK [1][-]{section*.10}{Strengths,\040Weaknesses\040Opportunities,\040Threats\040\(SWOT\)\040of\040an\040interdisciplinary\040PhD\040-\040personal\040perspective}{chapter*.6}% 3
\BOOKMARK [1][-]{section*.12}{General\040context\040of\040the\040thesis}{chapter*.6}% 4
\BOOKMARK [1][-]{section*.13}{Organisation\040of\040the\040dissertation}{chapter*.6}% 5
\BOOKMARK [0][-]{chapter.1}{Immuno-biology\040of\040cancer}{}% 6
\BOOKMARK [1][-]{section.1.1}{Cancer\040disease}{chapter.1}% 7
\BOOKMARK [2][-]{subsection.1.1.1}{Historical\040understanding\040of\040cancer}{section.1.1}% 8
\BOOKMARK [2][-]{subsection.1.1.2}{Tumor\040micro\040environment\040as\040a\040complex\040system}{section.1.1}% 9
\BOOKMARK [3][-]{subsubsection.1.1.2.1}{What\040is\040Tumor\040Microenvironment\040\(TME\)}{subsection.1.1.2}% 10
\BOOKMARK [3][-]{subsubsection.1.1.2.2}{Interactions\040between\040TME\040and\040Tumor}{subsection.1.1.2}% 11
\BOOKMARK [4][-]{paragraph.1.1.2.2.1}{TME\040as\040a\040foe:\040inflammation}{subsubsection.1.1.2.2}% 12
\BOOKMARK [4][-]{paragraph.1.1.2.2.2}{TME\040seen\040as\040neutral}{subsubsection.1.1.2.2}% 13
\BOOKMARK [4][-]{paragraph.1.1.2.2.3}{TME\040as\040a\040friend:\040immunosurveillance}{subsubsection.1.1.2.2}% 14
\BOOKMARK [3][-]{subsubsection.1.1.2.3}{Two-faced\040nature\040of\040immune\040cells:\040context-dependent\040functional\040plasticity}{subsection.1.1.2}% 15
\BOOKMARK [3][-]{subsubsection.1.1.2.4}{Immune\040cell\040\(sub\)types\040in\040TME}{subsection.1.1.2}% 16
\BOOKMARK [3][-]{subsubsection.1.1.2.5}{Summary}{subsection.1.1.2}% 17
\BOOKMARK [1][-]{section.1.2}{Quantifying\040and\040qualifying\040immune\040infiltration\040\(data\)}{chapter.1}% 18
\BOOKMARK [2][-]{subsection.1.2.1}{Cell\040sorting}{section.1.2}% 19
\BOOKMARK [3][-]{subsubsection.1.2.1.1}{Flow\040cytometry}{subsection.1.2.1}% 20
\BOOKMARK [3][-]{subsubsection.1.2.1.2}{Mass\040cytometry}{subsection.1.2.1}% 21
\BOOKMARK [2][-]{subsection.1.2.2}{Microscope\040Staining}{section.1.2}% 22
\BOOKMARK [2][-]{subsection.1.2.3}{omics}{section.1.2}% 23
\BOOKMARK [3][-]{subsubsection.1.2.3.1}{Transcriptome}{subsection.1.2.3}% 24
\BOOKMARK [3][-]{subsubsection.1.2.3.2}{Epigenome}{subsection.1.2.3}% 25
\BOOKMARK [3][-]{subsubsection.1.2.3.3}{Single\040cell\040RNA-seq}{subsection.1.2.3}% 26
\BOOKMARK [1][-]{section.1.3}{From\040cancer\040phenotyping\040to\040immune\040therapies}{chapter.1}% 27
\BOOKMARK [2][-]{subsection.1.3.1}{Cancer\040immune\040phenotypes}{section.1.3}% 28
\BOOKMARK [3][-]{subsubsection.1.3.1.1}{Immunoscore}{subsection.1.3.1}% 29
\BOOKMARK [3][-]{subsubsection.1.3.1.2}{Immunophenoscore}{subsection.1.3.1}% 30
\BOOKMARK [3][-]{subsubsection.1.3.1.3}{Immune\040maps}{subsection.1.3.1}% 31
\BOOKMARK [3][-]{subsubsection.1.3.1.4}{Summary}{subsection.1.3.1}% 32
\BOOKMARK [2][-]{subsection.1.3.2}{Immune\040signatures\040-\040biological\040perspective}{section.1.3}% 33
\BOOKMARK [2][-]{subsection.1.3.3}{Cancer\040therapies}{section.1.3}% 34
\BOOKMARK [2][-]{subsection.1.3.4}{Recent\040progress\040in\040immuno-therapies}{section.1.3}% 35
\BOOKMARK [1][-]{section.1.4}{Biological\040dimension\040of\040the\040thesis}{chapter.1}% 36
\BOOKMARK [0][-]{chapter.2}{Mathematical\040foundation\040of\040cell-type\040deconvolution\040of\040biological\040data}{}% 37
\BOOKMARK [1][-]{section.2.1}{Introduction\040to\040supervised\040and\040unsupervised\040learning}{chapter.2}% 38
\BOOKMARK [1][-]{section.2.2}{Blind\040source\040separation}{chapter.2}% 39
\BOOKMARK [1][-]{section.2.3}{Finding\040optimal\040number\040of\040components\040and\040over-decomposition\040of\040transcriptopmes}{chapter.2}% 40
\BOOKMARK [1][-]{section.2.4}{Cell-type\040deconvolution\040models}{chapter.2}% 41
\BOOKMARK [2][-]{subsection.2.4.1}{basis\040matrix}{section.2.4}% 42
\BOOKMARK [2][-]{subsection.2.4.2}{regression\040algorithm}{section.2.4}% 43
\BOOKMARK [2][-]{subsection.2.4.3}{Others}{section.2.4}% 44
\BOOKMARK [1][-]{section.2.5}{Short\040review\040of\040most\040popular\040cell-type\040deconvolution\040tools}{chapter.2}% 45
\BOOKMARK [1][-]{section.2.6}{Methodological\040dimension\040of\040the\040thesis}{chapter.2}% 46
\BOOKMARK [0][-]{chapter.3}{Study\040of\040sensitivity\040and\040reproducibility\040of\040known\040methods}{}% 47
\BOOKMARK [1][-]{section.3.1}{Reproducibility\040of\040NMF\040versus\040ICA\040\(vs\040CAM?\)}{chapter.3}% 48
\BOOKMARK [2][-]{subsection.3.1.1}{Comparing\040metagenes\040obtained\040with\040NMF\040vs\040ICA.}{section.3.1}% 49
\BOOKMARK [1][-]{section.3.2}{Impact\040of\040modification\040of\040signatures\040list\040on\040result\040for\040signature-based\040deconvolution\040methods}{chapter.3}% 50
\BOOKMARK [0][-]{chapter.4}{Deconvolution\040of\040transcriptomes\040and\040methylomes}{}% 51
\BOOKMARK [1][-]{section.4.1}{From\040blind\040deconvolution\040to\040cell-type\040quantification:\040general\040overview}{chapter.4}% 52
\BOOKMARK [2][-]{subsection.4.1.1}{The\040ICA-based\040deconvolution\040of\040Transcriptomes}{section.4.1}% 53
\BOOKMARK [2][-]{subsection.4.1.2}{Interpretation\040of\040Independent\040components}{section.4.1}% 54
\BOOKMARK [3][-]{subsubsection.4.1.2.1}{Correlation\040based\040identification\040of\040confounding\040factors}{subsection.4.1.2}% 55
\BOOKMARK [3][-]{subsubsection.4.1.2.2}{Identification\040of\040immune\040cell\040types\040with\040enrichment\040test\040/\040other}{subsection.4.1.2}% 56
\BOOKMARK [2][-]{subsection.4.1.3}{Transforming\040metagenes\040into\040signature\040matrix}{section.4.1}% 57
\BOOKMARK [2][-]{subsection.4.1.4}{Regression-based\040estimation\040of\040cell-type\040proportions\040:\040solving\040system\040of\040equations}{section.4.1}% 58
\BOOKMARK [1][-]{section.4.2}{DeconICA\040R\040package\040for\040ICA-based\040deconvolution}{chapter.4}% 59
\BOOKMARK [2][-]{subsection.4.2.1}{Demo}{section.4.2}% 60
\BOOKMARK [0][-]{chapter.5}{Comparative\040analysis\040of\040cancer\040immune\040infiltration}{}% 61
\BOOKMARK [0][-]{chapter.6}{Heterogeneity\040of\040immune\040cell\040types}{}% 62
\BOOKMARK [0][-]{chapter.7}{Conclusions\040and\040perspectives}{}% 63
\BOOKMARK [0][-]{chapter*.24}{Annexes}{}% 64
\BOOKMARK [1][-]{section*.25}{PhD\040timeline\040for\040defence\040before\040the\040end\040of\040October\0402018}{chapter*.24}% 65
\BOOKMARK [1][-]{section*.27}{Thesis\040writing}{chapter*.24}% 66
\BOOKMARK [1][-]{section*.28}{Activity\040Report\0402017}{chapter*.24}% 67
